Though 4 of 22 cancer patients were diagnosed with pediatric adrenocortical carcinoma, the most common tumor among carriers of TP53 p.Gly334Arg was breast cancer (10 of 22 patients) with relatively late onset (range 30–65 years old). Here, TP53 is linked to cancer.